Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novonix (NVX) Cash & Current Investments (2020 - 2025)

Novonix's Cash & Current Investments history spans 6 years, with the latest figure at $79.9 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 87.48% year-over-year to $79.9 million; the TTM value through Dec 2025 reached $79.9 million, up 87.48%, while the annual FY2025 figure was $79.9 million, 87.48% up from the prior year.
  • Cash & Current Investments reached $79.9 million in Q4 2025 per NVX's latest filing, up from $42.6 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $148.3 million in Q2 2022 to a low of $42.6 million in Q4 2024.
  • Average Cash & Current Investments over 5 years is $92.3 million, with a median of $89.5 million recorded in 2022.
  • Peak YoY movement for Cash & Current Investments: skyrocketed 294.3% in 2021, then tumbled 45.88% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $105.2 million in 2021, then decreased by 5.89% to $99.0 million in 2022, then fell by 20.52% to $78.7 million in 2023, then crashed by 45.88% to $42.6 million in 2024, then surged by 87.48% to $79.9 million in 2025.
  • Per Business Quant, the three most recent readings for NVX's Cash & Current Investments are $79.9 million (Q4 2025), $42.6 million (Q4 2024), and $78.7 million (Q4 2023).